News Sentiment

OFIX sentiment intelligence

Orthofix Medical Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 54 Balanced news tone 70 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Medical Devices Read-through group
Latest close 11.63 Week of 10 Jul 2026
Weighted tone 54/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

74/100 classification confidence.

Company focus 70

directly relevant articles

Source quality 2

high-authority source matches

Trend context Trend inactive

+17.0% over one week, +24.9% over four weeks, trend inactive, and near fair-value range.

Latest direct headline Neutral

Orthofix will host an 8:30 a.m. call to review Q2 results

Market Reaction

Price moving ahead of tone

61/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 74/100 classification
One-week reaction 17.0% Price confirming higher
Trend fit Trend inactive 24.9% over four weeks
Fair value -18.7% Near fair-value range

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 14
Neutral 52
Negative 4

Relevance

Why the article matched

Direct first
Direct company coverage 70
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
Market source 17
TradingView 10
Stock Titan 4
Moomoo 4
TradingKey 4
The Globe and Mail 3
Investing.com 2
GuruFocus 2

Event Lens

What the news is about

Classified themes
Market update 28
Earnings 26
Analyst action 7
Guidance 4
Macro sensitivity 2
Deals and strategy 2
Regulatory and legal 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-30 of 70
TradingView Direct company coverage

Price to sales forward of Orthofix Medical Inc. – NASDAQ:OFIX

This article provides access to the Price to Sales Forward metric for Orthofix Medical Inc. (NASDAQ: OFIX) on the TradingView platform. It outlines how to navigate to the financial data for OFIX, focusing on the specific financial ratio. The content serves as a directory to finan

Tone
Neutral 50/100
Event
Market update
Published
10 Jul 2026 16:10
Source
TradingView
TradingView Direct company coverage

Enterprise value to EBIT forward of Orthofix Medical Inc. – NASDAQ:OFIX

This article displays the "Enterprise value to EBIT forward" for Orthofix Medical Inc. (NASDAQ: OFIX) on TradingView. The data is presented for a specific period, indicating its value and percentage change. The content highlights the financial metrics available for this medical t

Tone
Neutral 50/100
Event
Market update
Published
07 Jul 2026 20:41
Source
TradingView
TradingView Direct company coverage

Enterprise value to EBITDA forward of Orthofix Medical Inc. – NASDAQ:OFIX

This article displays the Enterprise Value to EBITDA forward for Orthofix Medical Inc. (NASDAQ: OFIX). It's a brief data point presented within the TradingView platform, indicating a financial metric for the company. The rest of the content consists of navigation, copyright, and

Tone
Neutral 50/100
Event
Market update
Published
07 Jul 2026 19:40
Source
TradingView
The Globe and Mail Direct company coverage

Orthofix Medical (OFIX) Receives a Buy from Barrington

Barrington analyst Michael Petusky maintained a Buy rating on Orthofix Medical (OFIX) with a price target of $17.00. This rating is consistent with a Strong Buy consensus among analysts, with an average price target of $15.50. The company recently reported quarterly revenue of $1

Tone
Positive 87/100
Event
Analyst action
Published
07 Jul 2026 19:10
Source
The Globe and Mail
TradingView Direct company coverage

Price to sales forward of Orthofix Medical Inc. – BOATS:OFIX

This article provides a brief snapshot of the "Price to sales forward" metric for Orthofix Medical Inc. (OFIX) listed on the Blue Ocean Alternative Trade System (BOATS). It indicates the current period's value, change, and percentage change for this financial metric. The content

Tone
Neutral 50/100
Event
Market update
Published
07 Jul 2026 14:40
Source
TradingView
Moomoo Direct company coverage

Orthofix Medical Is Maintained at Outperform by Barrington Research

Barrington Research has reiterated its "Outperform" rating on Orthofix Medical. This suggests the firm believes Orthofix will continue to perform well relative to the broader market or its industry peers.

Tone
Positive 69/100
Event
Analyst action
Published
07 Jul 2026 07:10
Source
Moomoo
TradingView Direct company coverage

Price to book forward of Orthofix Medical Inc. – NASDAQ:OFIX

This article provides access to the Price to Book Forward financial metric for Orthofix Medical Inc. (NASDAQ: OFIX) on the TradingView platform. It specifies that the data is for the U.S. market, under Health Technology and Medical Specialties. The content emphasizes financial da

Tone
Neutral 50/100
Event
Market update
Published
07 Jul 2026 06:40
Source
TradingView
TradingView Direct company coverage

Price to earnings forward of Orthofix Medical Inc. – NASDAQ:OFIX

The article provides the "Price to earnings forward" financial metric for Orthofix Medical Inc. (NASDAQ: OFIX). It references market data from ICE Data Services and FactSet, and notes that SEC filings are provided by Quartr. The content is presented in a financial data context.

Tone
Neutral 50/100
Event
Earnings
Published
06 Jul 2026 21:11
Source
TradingView
The Globe and Mail Direct company coverage

Orthofix Medical Sees Medicare Reimbursement Policy Restored

Orthofix Medical (OFIX) has announced that the Centers for Medicare & Medicaid Services (CMS) reversed its earlier decision regarding reimbursement policy for non-invasive bone growth stimulators. This reversal means claims from May 18, 2026, onward will be processed under previo

Tone
Positive 65/100
Event
Market update
Published
06 Jul 2026 20:11
Source
The Globe and Mail
Moomoo Direct company coverage

Orthofix Medical Shares Rise After Medicare Billing for Bone Growth Stimulators Expected to Return to Prior Rates

Orthofix Medical shares rose significantly after the Centers for Medicare & Medicaid Services (CMS) signaled that billing for bone growth stimulators would return to pre-July 2023 rates. This policy reversal is a major positive for the company, as it removes uncertainty and finan

Tone
Positive 86/100
Event
Macro sensitivity
Published
06 Jul 2026 19:40
Source
Moomoo
Investing.com Direct company coverage

Canaccord reiterates Orthofix Medical stock rating after CMS reversal

Canaccord Genuity reiterated a Buy rating and $18.00 price target on Orthofix Medical (NASDAQ:OFIX) shares following the Centers for Medicare & Medicaid Services’ (CMS) reversal of reimbursement changes for bone growth stimulators. The CMS's decision to rescind previously impleme

Tone
Positive 70/100
Event
Analyst action
Published
06 Jul 2026 16:11
Source
Investing.com
Investing.com South Africa Direct company coverage

Orthofix Medical stock surges on Medicare reimbursement reversal By Investing.com

Orthofix Medical Inc. shares surged 12% after Medicare reversed its changes to reimbursement rates for non-invasive bone growth stimulators. The Centers for Medicare & Medicaid Services withdrew modifications to billing requirements that had been implemented in May 2026, meaning

Tone
Positive 92/100
Event
Macro sensitivity
Published
06 Jul 2026 14:11
Source
Investing.com South Africa
marketscreener.com Direct company coverage

Barrington Raises Price Target on Orthofix Medical to $17 From $15, Keeps Outperform Rating

Barrington has increased its price target for Orthofix Medical Inc. (OFIX) to $17 from $15, while maintaining an "Outperform" rating on the stock. This adjustment comes as Orthofix Medical continues to present at healthcare conferences and announce expansions to its product portf

Tone
Positive 71/100
Event
Analyst action
Published
06 Jul 2026 12:11
Source
marketscreener.com
GuruFocus Direct company coverage

Orthofix Medical Inc. (OFIX) Sees 6.7% Pre-Market Increase

Orthofix Medical Inc. (OFIX) experienced a 6.7% pre-market surge, attributed to positive market sentiment ahead of the trading session and potential healthcare sector recovery. Despite the stock uptick, the company faces significant challenges in profitability and financial stren

Tone
Positive 59/100
Event
Market update
Published
06 Jul 2026 12:11
Source
GuruFocus
TradingView Direct company coverage

Enterprise value to revenue forward of Orthofix Medical Inc. – NASDAQ:OFIX

The article focuses on the enterprise value to revenue forward metric for Orthofix Medical Inc. (NASDAQ: OFIX). It appears to be a financial data entry page from TradingView, providing an overview of the company's financial metrics. The content itself seems to be a placeholder or

Tone
Neutral 50/100
Event
Earnings
Published
05 Jul 2026 22:41
Source
TradingView
TMX Newsfile Direct company coverage

SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Orthofix

Faruqi & Faruqi, LLP is investigating potential claims against Orthofix Medical Inc. following a federal securities class action lawsuit. The investigation centers on allegations that Orthofix issued false and misleading statements regarding its management team, leading to a sign

Tone
Negative 26/100
Event
Regulatory and legal
Published
05 Jul 2026 05:41
Source
TMX Newsfile
Insider Monkey Direct company coverage

Orthofix Medical (OFIX) Among the Best Small-Cap Growth Stocks To Buy Now

Orthofix Medical Inc. (NASDAQ: OFIX) is highlighted as one of the best small-cap growth stocks to invest in, despite a recent 22% stock decline. Analysts remain bullish, forecasting over 54% upside. The medical device company reported strong revenue for fiscal Q1 2026, exceeding

Tone
Neutral 50/100
Event
Earnings
Published
03 Jul 2026 13:40
Source
Insider Monkey
GuruFocus Direct company coverage

Orthofix Medical (OFIX) Surges 10% After CMS Reversal on Bone Gr

Orthofix Medical (OFIX) saw its stock surge by approximately 10% in after-hours trading following the Centers for Medicare & Medicaid Services (CMS) rescinding an order that would have reclassified non-invasive bone growth stimulators. This reversal means the devices will continu

Tone
Positive 70/100
Event
Market update
Published
03 Jul 2026 07:39
Source
GuruFocus
Moomoo Direct company coverage

Stocks to Watch: Seer, Orthofix Medical, Halozyme Therapeutics

This article identifies several stocks to watch, including Seer, Orthofix Medical, and Halozyme Therapeutics. The selections are likely based on recent news, financial performance, or market activity concerning these companies. Investors may consider these stocks for potential op

Tone
Neutral 50/100
Event
Market update
Published
02 Jul 2026 23:40
Source
Moomoo
Stock Titan Direct company coverage

Orthofix (OFIX) expects Medicare bone stimulator reimbursement to return to prior levels

Orthofix Medical Inc. (OFIX) expects Medicare reimbursement rates for its non-invasive bone growth stimulators to revert to prior levels after the Centers for Medicare & Medicaid Services (CMS) withdrew billing changes. CMS initially altered billing rules following the FDA's recl

Tone
Positive 65/100
Event
Guidance
Published
02 Jul 2026 19:39
Source
Stock Titan
Simply Wall Street Direct company coverage

Orthofix Medical (Nasdaq:OFIX) - Stock Analysis

Orthofix Medical (OFIX) is trading significantly below its estimated fair value and analysts project a substantial price increase. Despite currently being unprofitable, the company has released new medical devices and provided earnings guidance for upcoming years. Recent updates

Tone
Negative 35/100
Event
Earnings
Published
29 Jun 2026 05:09
Source
Simply Wall Street
TradingView Direct company coverage

Orthofix Medical, Inc. Actuals & Estimates (NASDAQ:OFIX)

This article provides an overview of Orthofix Medical Inc. (OFIX) stock, including its current price, market capitalization, and analyst forecasts. It also details financial actuals and estimates, discusses past earnings reports, and confirms that the company does not pay dividen

Tone
Neutral 50/100
Event
Earnings
Published
26 Jun 2026 13:40
Source
TradingView